Literature DB >> 24042216

The serotonin 5-HT7 receptors: two decades of research.

Evelien Gellynck1, Karen Heyninck, Kjetil W Andressen, Guy Haegeman, Finn Olav Levy, Peter Vanhoenacker, Kathleen Van Craenenbroeck.   

Abstract

Like most neurotransmitters, serotonin possesses a simple structure. However, the pharmacological consequences are more complex and diverse. Serotonin is involved in numerous functions in the human body including the control of appetite, sleep, memory and learning, temperature regulation, mood, behavior, cardiovascular function, muscle contraction, endocrine regulation, and depression. Low levels of serotonin may be associated with several disorders, namely increase in aggressive and angry behaviors, clinical depression, Parkinson's disease, obsessive-compulsive disorder, eating disorders, migraine, irritable bowel syndrome, tinnitus, and bipolar disease. These effects are mediated via different serotonin (5-HT) receptors. In this review, we will focus on the last discovered member of this serotonin receptor family, the 5-HT7 receptor. This receptor belongs to the G protein-coupled receptor superfamily and was cloned two decades ago. Later, different splice variants were described but no major functional differences have been described so far. All 5-HT7 receptor variants are coupled to Gαs proteins and stimulate cAMP formation. Recently, several interacting proteins have been reported, which can influence receptor signaling and trafficking.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24042216     DOI: 10.1007/s00221-013-3694-y

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  112 in total

1.  Tight association of the human Mel(1a)-melatonin receptor and G(i): precoupling and constitutive activity.

Authors:  F Roka; L Brydon; M Waldhoer; A D Strosberg; M Freissmuth; R Jockers; C Nanoff
Journal:  Mol Pharmacol       Date:  1999-11       Impact factor: 4.436

2.  The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.

Authors:  Kurt A Krobert; Finn Olav Levy
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

3.  Expression patterns of 5-HT7 receptor isoforms in the rat digestive tract.

Authors:  H Liu; H R Irving; I M Coupar
Journal:  Life Sci       Date:  2001-10-12       Impact factor: 5.037

4.  Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.

Authors:  Kurt A Krobert; Kjetil Wessel Andressen; Finn Olav Levy
Journal:  Eur J Pharmacol       Date:  2006-02-17       Impact factor: 4.432

Review 5.  G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.

Authors:  Graeme Milligan
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

6.  Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor.

Authors:  Carol Smith; Tariq Rahman; Nicole Toohey; Joseph Mazurkiewicz; Katharine Herrick-Davis; Milt Teitler
Journal:  Mol Pharmacol       Date:  2006-07-26       Impact factor: 4.436

7.  Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C epsilon resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells.

Authors:  Klaus Lieb; Lisa Biersack; Anne Waschbisch; Sonja Orlikowski; Ravi Shankar Akundi; Eduardo Candelario-Jalil; Michael Hüll; Bernd L Fiebich
Journal:  J Neurochem       Date:  2005-05       Impact factor: 5.372

Review 8.  New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades.

Authors:  K L Pierce; L M Luttrell; R J Lefkowitz
Journal:  Oncogene       Date:  2001-03-26       Impact factor: 9.867

9.  Localization of 5-HT2A, 5-HT3, 5-HT5A and 5-HT7 receptor-like immunoreactivity in the rat cerebellum.

Authors:  Frederik J Geurts; Erik De Schutter; Jean-Pierre Timmermans
Journal:  J Chem Neuroanat       Date:  2002-06       Impact factor: 3.052

10.  Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.

Authors:  Pascal Bonaventure; Christine Dugovic; Michelle Kramer; Peter De Boer; Jaskaran Singh; Sue Wilson; Kirk Bertelsen; Jianing Di; Jonathan Shelton; Leah Aluisio; Lisa Dvorak; Ian Fraser; Brian Lord; Diane Nepomuceno; Abdellah Ahnaou; Wilhelmus Drinkenburg; Wenying Chai; Curt Dvorak; Steve Sands; Nicholas Carruthers; Timothy W Lovenberg
Journal:  J Pharmacol Exp Ther       Date:  2012-05-08       Impact factor: 4.030

View more
  28 in total

1.  Creation of the 5-hydroxytryptamine receptor 7 knockout rat as a tool for cardiovascular research.

Authors:  Elena Y Demireva; Huirong Xie; Emma D Flood; Janice M Thompson; Bridget M Seitz; Stephanie W Watts
Journal:  Physiol Genomics       Date:  2019-05-24       Impact factor: 3.107

2.  5-HT does not lower blood pressure in the 5-HT7 knockout rat.

Authors:  Bridget M Seitz; Elena Y Demireva; Huirong Xie; Gregory D Fink; Teresa Krieger-Burke; William M Burke; Stephanie W Watts
Journal:  Physiol Genomics       Date:  2019-05-24       Impact factor: 3.107

3.  Is the 5-hydroxytryptamine 7 Receptor Constitutively Active in the Vasculature? A Study in Veins/Vein.

Authors:  Stephanie W Watts; Emma D Flood; Janice M Thompson
Journal:  J Cardiovasc Pharmacol       Date:  2022-08-01       Impact factor: 3.271

Review 4.  Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases.

Authors:  Alejandro Quintero-Villegas; Sergio Iván Valdés-Ferrer
Journal:  Mol Med       Date:  2022-06-20       Impact factor: 6.376

Review 5.  Oh, the places you'll go! My many colored serotonin (apologies to Dr. Seuss).

Authors:  Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-23       Impact factor: 4.733

Review 6.  Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management.

Authors:  Folabomi A Oladosu; William Maixner; Andrea G Nackley
Journal:  Mayo Clin Proc       Date:  2015-08       Impact factor: 7.616

7.  Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivo.

Authors:  Filippo Andreetta; Lucia Carboni; Gillian Grafton; Ross Jeggo; Andrew D Whyment; Marco van den Top; Daniel Hoyer; David Spanswick; Nicholas M Barnes
Journal:  Br J Pharmacol       Date:  2016-03-21       Impact factor: 8.739

8.  5-HT7 receptor activation: procognitive and antiamnesic effects.

Authors:  A Meneses; G Perez-Garcia; G Liy-Salmeron; T Ponce-López; E Lacivita; M Leopoldo
Journal:  Psychopharmacology (Berl)       Date:  2014-07-31       Impact factor: 4.530

Review 9.  Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).

Authors:  H Bönisch; K B Fink; B Malinowska; G J Molderings; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-15       Impact factor: 3.000

10.  5-HT7 Receptor Restrains 5-HT-induced 5-HT2A Mediated Contraction in the Isolated Abdominal Vena Cava.

Authors:  Romina Gonzalez-Pons; Kiera McRae; Janice M Thompson; Stephanie W Watts
Journal:  J Cardiovasc Pharmacol       Date:  2021-08-01       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.